| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1106678954 |
| P356 | DOI | 10.1186/S12886-018-0910-3 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12886-018-0910-3 |
| P932 | PMC publication ID | 6126033 |
| P698 | PubMed publication ID | 30185156 |
| P2093 | author name string | Joo Youn Oh | |
| Ji-Won Kwon | |||
| Yongseok Mun | |||
| P2860 | cites work | Symptoms, visual function, and mucin expression of eyes with tear film instability | Q48023313 |
| Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study. | Q50442111 | ||
| The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear. | Q53082310 | ||
| A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore. | Q53625697 | ||
| The impact of contact lens wear and visual display terminal work on ocular surface and tear functions in office workers | Q84838139 | ||
| Prevalence and risk factors of dry eye disease in Japan: Koumi study | Q84884980 | ||
| [Clinical characteristics of short tear film breakup time (BUT) -type dry eye] | Q86051603 | ||
| P2Y2 receptor agonists for the treatment of dry eye disease: a review | Q24608339 | ||
| New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye Society | Q28067433 | ||
| Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy. | Q33686673 | ||
| Diquafosol tetrasodium: a novel dry eye therapy | Q35609725 | ||
| Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes | Q35647454 | ||
| Diquafosol ophthalmic solution for dry eye treatment | Q38030453 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye. | Q39229990 | ||
| A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan | Q40343307 | ||
| Clinical usefulness of diquafosol for real-world dry eye patients: a prospective, open-label, non-interventional, observational study | Q42692109 | ||
| Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study | Q44959502 | ||
| Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. | Q45122469 | ||
| Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. | Q45372415 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 237 | |
| P577 | publication date | 2018-09-05 | |
| P1433 | published in | BMC Ophthalmology | Q15765692 |
| P1476 | title | Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease | |
| P478 | volume | 18 |
| Q95266671 | Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use | cites work | P2860 |
Search more.